Rob Whitley examines barriers and facilitators to recovery within both health services and the wider socio-cultural environment.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.

Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

Gérard Lebel is a liaison for the Evaluation-Liaison Module, a service that responds to requests for psychiatric consultations from individuals referred by a physician.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Camillo Zacchia is Senior advisor, Mental Health Education Office (MHEO) at the Douglas Institute.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.